JU
Jubilant Pharmova
JUBLPHARMA.NS·NSENoida INFounded 19786,000 employees
Small CappharmaPublicOncologyRespiratory
Platform: Specialty Radio
Market Cap
$1B
All Drugs
2
Clinical Trials
2
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (JUBLPHARMA.NS)
Loading JUBLPHARMA.NS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| JUB-6434 | JUB-6434 | Phase 1 | 1 | MDM2 | Heart FailurePompe | ||
| JUB-6215 | JUB-6215 | Phase 2/3 | 1 | CD20 | EpilepsyOCD |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Jubilant Pharmova trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)